EcoR1 Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,346,475	Closed	-$21.9M	–	65
2024 Q2	$21.9M	Sell	1,346,475 -4,645,004	-78%	-$75M	0.67%	32
2024 Q1	$111M	Hold	5,991,479	–	–	2.81%	12
2023 Q4	$188M	Hold	5,991,479	–	–	4.87%	6
2023 Q3	$125M	Hold	5,991,479	–	–	4.25%	7
2023 Q2	$143M	Hold	5,991,479	–	–	3.78%	9
2023 Q1	$113M	Hold	5,991,479	–	–	3.63%	9
2022 Q4	$95.4M	Hold	5,991,479	–	–	2.9%	10
2022 Q3	$98M	Hold	5,991,479	–	–	2.89%	10
2022 Q2	$84.4M	Hold	5,991,479	–	–	2.93%	11
2022 Q1	$145M	Buy	5,991,479 +2,930,886	+96%	+$70.9M	4.54%	7
2021 Q4	$71.4M	Buy	+3,060,593	New	+$61.6M	2.28%	13
2020 Q3	–	Sell	-135,413	Closed	-$6.56M	–	50
2020 Q2	$6.56M	Sell	135,413 -188,476	-58%	-$9.05M	0.49%	31
2020 Q1	$13.7M	Sell	323,889 -176,111	-35%	-$7.26M	1.43%	22
2019 Q4	$21.4M	Buy	+500,000	New	+$21.8M	2.03%	19